Indian drug firm Sun Pharma may have to shell out up to Rs 1,000 crore for acquiring the Israel-based Taro Pharma-ceuticals. “If we are able to get all the shares of Taro pharma-ceuticals, including promo-ters’, then the total cost would be up to Rs 1,000 crore,” the firm said.
Explore Business Standard